These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23477712)

  • 1. L35. Fc receptors and cell activation.
    Monteiro RC
    Presse Med; 2013 Apr; 42(4 Pt 2):598-9. PubMed ID: 23477712
    [No Abstract]   [Full Text] [Related]  

  • 2. How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.
    Kettritz R
    Clin Exp Immunol; 2012 Sep; 169(3):220-8. PubMed ID: 22861361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NETs in pathogenesis of vasculitis].
    Nakazawa D; Nishio S; Tomaru U; Atsumi T; Ishizu A
    Nihon Jinzo Gakkai Shi; 2014; 56(2):117-23. PubMed ID: 24730349
    [No Abstract]   [Full Text] [Related]  

  • 4. L34. Neutrophils in ANCA-associated vasculitis: still under investigation.
    Witko-Sarsat V
    Presse Med; 2013 Apr; 42(4 Pt 2):595-7. PubMed ID: 23481359
    [No Abstract]   [Full Text] [Related]  

  • 5. L8. Animal models of ANCA associated vasculitis: the contribution of autoantibodies and autoreactive T cells.
    Heeringa P
    Presse Med; 2013 Apr; 42(4 Pt 2):515-7. PubMed ID: 23453995
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutrophils are not consistently activated by antineutrophil cytoplasmic antibodies in vitro.
    Popat RJ; Robson MG
    Ann Rheum Dis; 2019 May; 78(5):709-711. PubMed ID: 30514699
    [No Abstract]   [Full Text] [Related]  

  • 7. L10. Animal models of ANCA-associated vasculitis: effector mechanisms and experimental therapies.
    Schreiber A
    Presse Med; 2013 Apr; 42(4 Pt 2):520-3. PubMed ID: 23453497
    [No Abstract]   [Full Text] [Related]  

  • 8. Native myeloperoxidase is required to make the experimental vasculitis model.
    Nonokawa M; Suzuki K; Hayashi H; Nishibata Y; Masuda S; Nakazawa D; Tanaka S; Tomaru U; Ishizu A
    Arthritis Res Ther; 2019 Dec; 21(1):296. PubMed ID: 31864385
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement system activation in ANCA vasculitis: A translational success story?
    Kallenberg CG; Heeringa P
    Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo?
    Bosch X; Guilabert A; Espinosa G; Mirapeix E
    Trends Immunol; 2008 Jun; 29(6):280-9. PubMed ID: 18440274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of neutrophils in causing antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Schreiber A; Choi M
    Curr Opin Hematol; 2015 Jan; 22(1):60-6. PubMed ID: 25394311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil activation in anti-proteinase 3-positive vasculitis--a prospective study.
    Wikman A; Lundahl J; Jacobson SH
    Scand J Immunol; 2005 Dec; 62(6):539-45. PubMed ID: 16316421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune regulatory mechanisms in ANCA-associated vasculitides.
    Lepse N; Abdulahad WH; Kallenberg CG; Heeringa P
    Autoimmun Rev; 2011 Dec; 11(2):77-83. PubMed ID: 21856453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of proinflammatory genes in neutrophil-enriched granulocytes stimulated with native anti-PR3 autoantibodies.
    Surmiak M; Kaczor M; Sanak M
    J Physiol Pharmacol; 2012 Jun; 63(3):249-56. PubMed ID: 22791638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease.
    Kambas K; Chrysanthopoulou A; Vassilopoulos D; Apostolidou E; Skendros P; Girod A; Arelaki S; Froudarakis M; Nakopoulou L; Giatromanolaki A; Sidiropoulos P; Koffa M; Boumpas DT; Ritis K; Mitroulis I
    Ann Rheum Dis; 2014 Oct; 73(10):1854-63. PubMed ID: 23873874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L33. Neutrophil in immunity: a key modulator.
    Cassatella MA
    Presse Med; 2013 Apr; 42(4 Pt 2):594-5. PubMed ID: 23453215
    [No Abstract]   [Full Text] [Related]  

  • 18. An unusual presentation of C-ANCA vasculitis.
    Gavrilovski M; Kakar P; Rendle J; Lawrence E; Kee K; Sathanathan R
    QJM; 2012 Nov; 105(11):1105-7. PubMed ID: 21920993
    [No Abstract]   [Full Text] [Related]  

  • 19. Working Intricately with Moh Daha.
    Rees A
    Mol Immunol; 2015 Nov; 68(1):50-2. PubMed ID: 26597207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic role of anti-neutrophil cytoplasmic antibodies in vasculitis.
    Pankhurst T; Savage CO
    Curr Opin Pharmacol; 2006 Apr; 6(2):190-6. PubMed ID: 16483847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.